BRANCATELLI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 7.208
EU - Europa 3.502
AS - Asia 782
SA - Sud America 8
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 11.517
Nazione #
US - Stati Uniti d'America 7.192
IT - Italia 1.248
UA - Ucraina 602
CN - Cina 579
FI - Finlandia 446
DE - Germania 390
IE - Irlanda 226
GB - Regno Unito 161
SE - Svezia 119
SG - Singapore 98
RU - Federazione Russa 95
FR - Francia 61
RO - Romania 43
BE - Belgio 36
IN - India 27
KR - Corea 23
HK - Hong Kong 14
CA - Canada 13
CH - Svizzera 13
ES - Italia 13
NL - Olanda 12
IR - Iran 10
TR - Turchia 9
PL - Polonia 7
EU - Europa 6
AT - Austria 5
CZ - Repubblica Ceca 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
AU - Australia 3
BR - Brasile 3
GR - Grecia 3
ID - Indonesia 3
VN - Vietnam 3
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
PH - Filippine 2
PT - Portogallo 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GH - Ghana 1
IQ - Iraq 1
JP - Giappone 1
LB - Libano 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 11.517
Città #
Fairfield 1.087
Ashburn 651
Chandler 632
Woodbridge 611
Wilmington 462
Houston 444
Ann Arbor 391
Seattle 381
Cambridge 368
Jacksonville 339
Dublin 226
Palermo 197
Medford 194
Nanjing 145
Princeton 131
Des Moines 100
Altamura 99
Tulsa 84
Lawrence 75
Beijing 70
Dearborn 69
New York 66
Boardman 61
San Diego 57
Singapore 55
Jinan 47
Milan 43
Nanchang 41
Shenyang 40
Ludwigshafen am Rhein 38
Changsha 37
Brussels 35
Tianjin 31
Rome 30
Jiaxing 29
Hebei 28
Venice 27
Verona 23
Seongnam 22
Saint Petersburg 20
Krefeld 18
London 18
Ningbo 17
Redwood City 17
Falls Church 16
San Paolo di Civitate 15
Zhengzhou 14
Lanzhou 13
Washington 12
Bremen 11
Florence 11
Kumar 11
Phoenix 11
Pune 11
Hangzhou 10
Orange 10
Ottawa 10
Catania 9
Auburn Hills 8
Central 8
Chicago 8
Helsinki 8
Kilburn 8
Tehran 8
Brescia 7
Los Angeles 7
Taizhou 7
Düsseldorf 6
Fuzhou 6
Hefei 6
Izmir 6
Kunming 6
Norwalk 6
Caltanissetta 5
Guangzhou 5
Haikou 5
Moscow 5
Napoli 5
Perugia 5
San Mateo 5
Abidjan 4
Bologna 4
Brno 4
Casalnuovo di Napoli 4
Caserta 4
Central District 4
Chiswick 4
Hounslow 4
Naples 4
Padova 4
Parma 4
Ponte Buggianese 4
Prescot 4
Saronno 4
Serra 4
Shanghai 4
Torino 4
Turin 4
Vicenza 4
West Jordan 4
Totale 7.940
Nome #
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 217
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 200
ASPETTI TC ED RM NELLA RETRAZIONE CAPSULARE EPATICA 181
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 172
Hepatocellular carcinoma: Comparison of two different periods at the same center 166
Treatment of hepatocellular carcinoma: present and future. 164
The cheating liver: imaging of focal steatosis and fatty sparing 164
Whipple's pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center 160
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 157
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid 156
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents 155
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 151
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 147
Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? 145
Peliosis hepatis: spectrum of imaging findings 144
Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history 144
CHRONIC ATRIAL FIBRILLATION IN PRESENCE OF AORTIC STENOSIS IN A PATIENT WITH POLYSPLENIA SYNDROME 144
Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI 143
Le calcificazioni pancreatiche sono specifiche nella diagnosi di pancreatite cronica? Studio con TC multidetettore. 142
Ultrasonic evaluation with second harmonic imaging and SonoVue in the assessment of cerebral perfusion in diabetic patients: a case-control study 134
Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device-Initial observations. 134
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP 133
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 126
Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy 126
Aspetti con TC ed RM delle cisti peribiliari 125
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines 125
Budd-Chiari syndrome: spectrum of imaging findings. 124
Computed tomographic imaging of hepatocellular carcinoma. 124
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. 123
Imaging appearance of treated hepatocellular carcinoma. 119
Focal liver lesions hyperintense on T1-weighted magnetic resonance images. 118
Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver 118
Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine 118
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 116
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study 115
Assessment of treatment response in hepatocellular carcinoma: a review of literature 115
Cirrhosis: CT and MR imaging evaluation. 112
Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. 112
CT and MR imaging of chemotherapy-induced hepatopathy 112
Moderne Diagnostik zystischer Leberläsionen und Hämangiome 110
Focal liver lesions in patients with cavernous transformation of the portal vein: diagnosis and MR features. 109
Are pancreatic calcifications specific for the diagnosis of chronic pancreatitis? A multidetector-row CT analysis. 108
Utility of CT in the diagnosis of pancreatic fistula after pancreaticoduodenectomy in patients with soft pancreas. 108
Utrastructural biologic effects of sonography with pulse inversion and microbubble contrast in rabbit liver 106
Science to practice: Should biopsy be performed in potential liver donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation? 103
Fibropolycystic liver disease: CT and MR imaging findings. 103
VALUTAZIONE DELLA PERFUSIONE CEREBRALE CON ECOGRAFIA TRANSCRANICA (TCCD) E MEZZO DI CONTRASTO (MDC) IN PAZIENTI DIABETICI: STUDIO CASO-CONTROLLO 103
Imaging approach for evaluation of focal liver lesions 102
Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA 102
Education and Imaging. Hepatobiliary and pancreatic: Portal hypertensive biliopathy presenting as acute cholangitis. 100
Avoiding Pitfalls in the Interpretation of Gadoxetic Acid–Enhanced Magnetic Resonance Imaging 99
Imaging findings of hepatic focal nodular hyperplasia in men and women: are they really different? 95
Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. 94
Budd-Chiari Syndrome: spectrum of imaging findings. 93
Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase 93
Uncommon imaging evolutions of focal liver lesions in cirrhosis 92
Complications of hepatic echinococcosis: multimodality imaging approach 92
Gadoxetate disodium-enhanced magnetic resonance cholangiography for the noninvasive detection of an active bile duct leak after laparoscopic cholecystectomy. 91
Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI 91
Uncommon evolutions and complications of common benign liver lesions 89
Hepatic Sinusoidal Dilatation: A Review of Causes With Imaging-Pathologic Correlation 88
Focal confluent fibrosis: findings at CT and MRI in the cirrhotic liver 87
CT and MR imaging evaluation of hepatic adenoma. 85
Hepatocellular and fibrolamellar carcinoma 83
UTILITÀ DELLA TC NELLA DIAGNOSI DELLA FISTOLA PANCREATICA DOPO DUODENOCEFALOPANCREASECTOMIA IN PAZIENTI CON SOFT PANCREAS 83
Hepatocellular carcinoma (HCC) with indeterminate findings at initial CT or MRI: Does imaging follow-up allow detection of conclusive imaging findings before significant tumor growth? 83
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. 81
Aspetti delle lesioni cistiche epatiche con TC ed RM obiettivi 79
Congenital hepatic fibrosis: CT findings in 18 adults. 79
Three-dimensional contrast-enhanced ultrasound versus conventional two dimensional contrast-enhanced ultrasound in the evaluation of therapeutic response of hepatocellular carcinoma after local therapies. 77
Interreader reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: A large international multireader study 72
The abnormal hepatic morphology: not always cirrhosis 71
Cerebral Vessels. 70
Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation 69
causes of false positive interpretation for hepatocellular carcinoma in cirrhosis 68
Arterially enhancing liver lesions: significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging. 68
Role of 64-slice CT multiplanar reconstructions in acute mechanical bowel obstruction 68
Biases Likely Invalidate the Conclusions (LETTER). 67
Hepatocellular carcinoma in cirrhotic patients at MDCT: hepatic venous phase versus delayed phase for the detection of tumour washout 67
Morphologic changes of the liver: how to recognize and analyze at CT and MRI 67
GROWTH RATE OF SMALL (≤2CM) HCC IN CIRRHOTIC PATIENTS: DETERMINING OPTIMAL SCREENING INTERVAL WITH SERIAL CT AND MRI 64
INTERMODALITY AGREEMENT FOR THE DIAGNOSIS OF SMALL (≤2CM) HEPATOCELLULAR CARCINOMAS (HCCS) IN PATIENTS WITH CIRRHOSIS 64
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? 64
Arterially enhancing liver lesion: significance of sustained enhancement on delayed phase with MR imaging 59
Tumor enhancement at contrast-enhanced CT and Gd-enhanced MRI for the assessment of treatment response of hepatocellular carcinoma (HCC) after sorafenib 59
Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability 59
Benign liver lesions: Cysts and Cystic-Like Lesions. 58
Ernie della parete addominale ed ernie interne: ruolo della tcmd nella gestione clinica del paziente. 58
Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting 58
Solitary necrotic nodules of the liver: cross sectional imaging findings and follow-up in nine patients 57
Hepatocellular Adenoma 57
Common and uncommon pitfalls in pancreatic imaging: it is not always cancer 57
LONG-TERM NATURAL HISTORY OF FOCAL CONFLUENT FIBROSIS (FCF) IN THE CIRRHOTIC LIVER: A CT SERIAL ANALYSIS 56
DETECTION AND CHARACTERIZATION OF FOCAL LESIONS IN HEPATIC STEATOSIS: HELICAL CT OR MRI? 56
CT AND MR INAGING FINDINGS IN HEPATIC PELIOSIS 54
Non cirrhotic liver: the TDTU (“too difficult to understand”) hypervascular lesions 54
Case 80: splenosis. 53
Cavernous hemangioma associated with other hepatic masses at CT and MRI 53
Cavernous haemangioma associated with other hepatic masses at CT and MRI 53
Growth rate of small (≤2 cm) HCC in cirrhotic patient: determining optimal screening interval with serial CT or MRI. 52
Totale 10.221
Categoria #
all - tutte 44.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.111 349 163 192 285 336 379 337 184 320 139 266 161
2020/20211.739 71 181 83 178 170 88 158 129 184 158 179 160
2021/20221.427 79 298 38 46 50 86 60 62 219 171 61 257
2022/20231.994 213 315 44 177 257 289 104 178 239 20 113 45
2023/2024846 39 132 41 85 71 180 90 37 22 35 19 95
2024/202558 58 0 0 0 0 0 0 0 0 0 0 0
Totale 11.989